Parental fear of progression in juvenile idiopathic arthritis and type 1 diabetes - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Fear of Disease Progression Among Parents of Children With Juvenile Idiopathic Arthritis or Type 1 Diabetes

  • By

  • Bethany Richmond

  • Louise Sharpe

  • Ruth Colagiuri

  • Jemma Todd

  • October 9, 2026

Share

Clinical Scorecard: Fear of Disease Progression Among Parents of Children With Juvenile Idiopathic Arthritis or Type 1 Diabetes

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Fear of Disease Progression Among Parents of Children With Juvenile Idiopathic Arthritis or Type 1 Diabetes
Key MechanismsFear of disease progression (FoP) is fear, worry, or concern about the possibility that a disease will worsen or progress. The authors examined whether parents of youth with JIA or T1DM experience these concerns.
Target PopulationPopulation described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • Elevated FoP was identified in 76% of participating parents.
  • Higher parental FoP was associated with less favourable parent and youth psychosocial outcomes, based on parent reports.
  • After covariate adjustment, parental FoP accounted for an additional 1.6% of variance in parent-reported youth health-related quality of life.
  • The study was cross-sectional and relied on parent-reported questionnaires.
  • The authors call for future research on understanding and treating parental FoP.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • The article identifies improved screening and support addressing parents’ concerns about disease progression as a research, practice, or policy need; it does not provide a monitoring protocol.

      Risks

        Patient & Prescribing Data

        The sample comprised 124 parents of youth aged 2–18 years (mean age 11.36 years, SD 3.90); 107 were mothers and 17 were fathers.

        No treatment or prescribing intervention was evaluated. The study assessed parental FoP and parent-reported psychosocial outcomes.

        Clinical Best Practices

        • Interpret the findings in light of the cross-sectional design and parent-reported measures.
        • The article identifies improved screening and support addressing parents’ concerns about disease progression as a research, practice, or policy need.

        Related Resources & Content

        Original Source(s)

        Related Content